BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31033783)

  • 21. Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.
    Rein A; Geron I; Kugler E; Fishman H; Gottlieb E; Abramovich I; Giladi A; Amit I; Mulet-Lazaro R; Delwel R; Gröschel S; Levin-Zaidman S; Dezorella N; Holdengreber V; Rao TN; Yacobovich J; Steinberg-Shemer O; Huang QH; Tan Y; Chen SJ; Izraeli S; Birger Y
    Haematologica; 2023 Sep; 108(9):2316-2330. PubMed ID: 36475518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute lymphoblastic leukemia in a patient with MonoMAC syndrome/GATA2 haploinsufficiency.
    Koegel AK; Hofmann I; Moffitt K; Degar B; Duncan C; Tubman VN
    Pediatr Blood Cancer; 2016 Oct; 63(10):1844-7. PubMed ID: 27232273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency.
    Kozyra EJ; Pastor VB; Lefkopoulos S; Sahoo SS; Busch H; Voss RK; Erlacher M; Lebrecht D; Szvetnik EA; Hirabayashi S; Pasaulienė R; Pedace L; Tartaglia M; Klemann C; Metzger P; Boerries M; Catala A; Hasle H; de Haas V; Kállay K; Masetti R; De Moerloose B; Dworzak M; Schmugge M; Smith O; Starý J; Mejstrikova E; Ussowicz M; Morris E; Singh P; Collin M; Derecka M; Göhring G; Flotho C; Strahm B; Locatelli F; Niemeyer CM; Trompouki E; Wlodarski MW;
    Leukemia; 2020 Oct; 34(10):2673-2687. PubMed ID: 32555368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First Korean case of Emberger syndrome (primary lymphedema with myelodysplasia) with a novel GATA2 gene mutation.
    Seo SK; Kim KY; Han SA; Yoon JS; Shin SY; Sohn SK; Moon JH
    Korean J Intern Med; 2016 Jan; 31(1):188-90. PubMed ID: 26767875
    [No Abstract]   [Full Text] [Related]  

  • 25. The evolution of cellular deficiency in GATA2 mutation.
    Dickinson RE; Milne P; Jardine L; Zandi S; Swierczek SI; McGovern N; Cookson S; Ferozepurwalla Z; Langridge A; Pagan S; Gennery A; Heiskanen-Kosma T; Hämäläinen S; Seppänen M; Helbert M; Tholouli E; Gambineri E; Reykdal S; Gottfreðsson M; Thaventhiran JE; Morris E; Hirschfield G; Richter AG; Jolles S; Bacon CM; Hambleton S; Haniffa M; Bryceson Y; Allen C; Prchal JT; Dick JE; Bigley V; Collin M
    Blood; 2014 Feb; 123(6):863-74. PubMed ID: 24345756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GATA2 Deficiency in Adult Life Is Characterized by Phenotypic Diversity and Delayed Diagnosis.
    Shamriz O; Zahalka N; Simon AJ; Lev A; Barel O; Mor N; Tal Y; Segel MJ; Somech R; Yonath H; Toker O
    Front Immunol; 2022; 13():886117. PubMed ID: 35603181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.
    Wlodarski MW; Hirabayashi S; Pastor V; Starý J; Hasle H; Masetti R; Dworzak M; Schmugge M; van den Heuvel-Eibrink M; Ussowicz M; De Moerloose B; Catala A; Smith OP; Sedlacek P; Lankester AC; Zecca M; Bordon V; Matthes-Martin S; Abrahamsson J; Kühl JS; Sykora KW; Albert MH; Przychodzien B; Maciejewski JP; Schwarz S; Göhring G; Schlegelberger B; Cseh A; Noellke P; Yoshimi A; Locatelli F; Baumann I; Strahm B; Niemeyer CM;
    Blood; 2016 Mar; 127(11):1387-97; quiz 1518. PubMed ID: 26702063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GATA2 and marrow failure.
    Fabozzi F; Strocchio L; Mastronuzzi A; Merli P
    Best Pract Res Clin Haematol; 2021 Jun; 34(2):101278. PubMed ID: 34404529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.
    Kotmayer L; Romero-Moya D; Marin-Bejar O; Kozyra E; Català A; Bigas A; Wlodarski MW; Bödör C; Giorgetti A
    Br J Haematol; 2022 Nov; 199(4):482-495. PubMed ID: 35753998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel GATA2 distal enhancer mutation results in MonoMAC syndrome in 2 second cousins.
    West RR; Bauer TR; Tuschong LM; Embree LJ; Calvo KR; Tillo D; Davis J; Holland SM; Hickstein DD
    Blood Adv; 2023 Oct; 7(20):6351-6363. PubMed ID: 37595058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CENTRAL RETINAL VEIN OCCLUSION IN GATA2 DEFICIENCY.
    Berry D; Fekrat S
    Retin Cases Brief Rep; 2019 Spring; 13(2):181-184. PubMed ID: 28248742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Invasive mucorales sinusitis in a young patient with Emberger syndrome and newly diagnosed AML: A case report and literature review of invasive fungal infections in GATA2 deficiency.
    Chiu CY; Matsuo T; Wurster S; Gerstein Y; Hammond DE; Chien KS; DiNardo C; Kontoyiannis DP
    Mycoses; 2023 Dec; 66(12):1029-1034. PubMed ID: 37550272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. rs1573858 GATA-2 homozygote variant associated with pulmonary alveolar proteinosis, cytopenia and neurologic dysfunction.
    China N; Gurioli C; Maitan S; Poletti V
    Pulmonology; 2020; 26(3):178-180. PubMed ID: 31672593
    [No Abstract]   [Full Text] [Related]  

  • 34. GATA2 Deficiency in a Pediatric Patient.
    Mojica AM; Elizalde A
    J Allergy Clin Immunol Pract; 2019; 7(6):2021-2022. PubMed ID: 30894283
    [No Abstract]   [Full Text] [Related]  

  • 35. Folliculotropic mycosis fungoides associated with GATA2 deficiency: a new skin manifestation.
    Fertitta L; Fontbrune FS; Battistella M; De Masson A; Bergeron A; Ranta D; Vignon-Pennamen MD; Bagot M; Bouaziz JD
    Br J Dermatol; 2018 Dec; 179(6):1420-1421. PubMed ID: 30101490
    [No Abstract]   [Full Text] [Related]  

  • 36. GATA2 null mutation associated with incomplete penetrance in a family with Emberger syndrome.
    Brambila-Tapia AJL; García-Ortiz JE; Brouillard P; Nguyen HL; Vikkula M; Ríos-González BE; Sandoval-Muñiz RJ; Sandoval-Talamantes AK; Bobadilla-Morales L; Corona-Rivera JR; Arnaud-Lopez L
    Hematology; 2017 Sep; 22(8):467-471. PubMed ID: 28271814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lethal Influenza in Two Related Adults with Inherited GATA2 Deficiency.
    Sologuren I; Martínez-Saavedra MT; Solé-Violán J; de Borges de Oliveira E; Betancor E; Casas I; Oleaga-Quintas C; Martínez-Gallo M; Zhang SY; Pestano J; Colobran R; Herrera-Ramos E; Pérez C; López-Rodríguez M; Ruiz-Hernández JJ; Franco N; Ferrer JM; Bilbao C; Andújar-Sánchez M; Álvarez Fernández M; Ciancanelli MJ; Rodríguez de Castro F; Casanova JL; Bustamante J; Rodríguez-Gallego C
    J Clin Immunol; 2018 May; 38(4):513-526. PubMed ID: 29882021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful umbilical cord blood hematopoietic stem cell transplantation in pediatric patients with MDS/AML associated with underlying GATA2 mutations: two case reports and review of literature.
    Mallhi K; Dix DB; Niederhoffer KY; Armstrong L; Rozmus J
    Pediatr Transplant; 2016 Nov; 20(7):1004-1007. PubMed ID: 27416790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fifty Shades of GATA2 Mutation: A Case of Plasmablastic Lymphoma, Nontuberculous Mycobacterial Infection, and Myelodysplastic Syndrome.
    Fakhri B; Cashen AF; Duncavage EJ; Watkins MP; Wartman LD; Bartlett NL
    Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):e532-e535. PubMed ID: 31279773
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitative and qualitative impairments in GATA2 and myeloid neoplasms.
    Shimizu R; Yamamoto M
    IUBMB Life; 2020 Jan; 72(1):142-150. PubMed ID: 31675473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.